Oxidative Metabolism as a Modulator of Kratom’s Biological Actions

  • Soumen Chakraborty
    Center for Clinical Pharmacology, University of Health Sciences & Pharmacy and Washington University School of Medicine, St. Louis, Missouri 63110, United States
  • Rajendra Uprety
    Department of Neurology and Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York 10065, United States
  • Samuel T. Slocum
    Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
  • Takeshi Irie
    Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York 10065, United States
  • Valerie Le Rouzic
    Department of Neurology and Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York 10065, United States
  • Xiaohai Li
    Department of Molecular Therapeutics, Scripps Research Institute, Jupiter, Florida 33458, United States
  • Lisa L. Wilson
    Department of Pharmacodynamics, University of Florida, Gainesville, Florida 32610, United States
  • Brittany Scouller
    Centre for Biodiscovery, School of Biological Science, Victoria University of Wellington, Wellington 6012, New Zealand
  • Amy F. Alder
    Centre for Biodiscovery, School of Biological Science, Victoria University of Wellington, Wellington 6012, New Zealand
  • Andrew C. Kruegel
    Department of Chemistry, Columbia University, New York 10027, United States
  • Michael Ansonoff
    Department of Neuroscience and Cell Biology, Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey 08854-8021, United States
  • Andras Varadi
    Department of Neurology and Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York 10065, United States
  • Shainnel O. Eans
    Department of Pharmacodynamics, University of Florida, Gainesville, Florida 32610, United States
  • Amanda Hunkele
    Department of Neurology and Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York 10065, United States
  • Abdullah Allaoa
    Department of Neurology and Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York 10065, United States
  • Sanjay Kalra
    Department of Neurology and Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York 10065, United States
  • Jin Xu
    Department of Neurology and Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York 10065, United States
  • Ying Xian Pan
    Department of Neurology and Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York 10065, United States
  • John Pintar
    Department of Neuroscience and Cell Biology, Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey 08854-8021, United States
  • Bronwyn M. Kivell
    Centre for Biodiscovery, School of Biological Science, Victoria University of Wellington, Wellington 6012, New Zealand
  • Gavril W. Pasternak
    Department of Neurology and Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York 10065, United States
  • Michael D. Cameron
    Department of Molecular Therapeutics, Scripps Research Institute, Jupiter, Florida 33458, United States
  • Jay P. McLaughlin
    Department of Pharmacodynamics, University of Florida, Gainesville, Florida 32610, United States
  • Dalibor Sames
    Department of Chemistry, Columbia University, New York 10027, United States
  • Susruta Majumdar
    Center for Clinical Pharmacology, University of Health Sciences & Pharmacy and Washington University School of Medicine, St. Louis, Missouri 63110, United States

Journal

Citations (1)*help

See more

Details 詳細情報について

Report a problem

Back to top